Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125004982 | 12500498 | 2 | F | 20160608 | 20160922 | 20160627 | 20160927 | EXP | FR-PFIZER INC-2016310891 | PFIZER | 71.00 | YR | M | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125004982 | 12500498 | 1 | PS | Tazocilline | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | D | 50750 | INJECTION | ||||||||
| 125004982 | 12500498 | 2 | SS | Tazocilline | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | D | 50750 | INJECTION | ||||||||
| 125004982 | 12500498 | 3 | SS | METOJECT | METHOTREXATE SODIUM | 1 | Subcutaneous | 20 MG, WEEKLY | 20 | MG | U | 0 | 20 | MG | /wk | ||||
| 125004982 | 12500498 | 4 | SS | PROFENID | KETOPROFEN | 1 | Oral | UNK | U | 0 | |||||||||
| 125004982 | 12500498 | 5 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | UNK | Y | 0 | |||||||||
| 125004982 | 12500498 | 6 | SS | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | 500 MG, 3X/DAY | 4500 | MG | Y | 0 | 500 | MG | TID | ||||
| 125004982 | 12500498 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 4 MG, DAILY | 0 | 4 | MG | |||||||||
| 125004982 | 12500498 | 8 | C | CEBUTID | FLURBIPROFEN | 1 | 200 MG, DAILY | 0 | 200 | MG | |||||||||
| 125004982 | 12500498 | 9 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 10 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 11 | C | SIMVASTATINE | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 12 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 125004982 | 12500498 | 13 | C | PROPOFOL. | PROPOFOL | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 14 | C | SULFENTANYL | SUFENTANIL | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 15 | C | ATRACURIUM | ATRACURIUM | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 16 | C | KETAMINE | KETAMINE | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 17 | C | CEFAZOLIN | CEFAZOLIN | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 18 | C | HYDROCORTISONE HEMISUCCINATE | HYDROCORTISONE HEMISUCCINATE | 1 | 500 MG, INTRA-OPERATIVE | 0 | 500 | MG | |||||||||
| 125004982 | 12500498 | 19 | C | HYDROCORTISONE HEMISUCCINATE | HYDROCORTISONE HEMISUCCINATE | 1 | 50 MG, 4X/DAY | 0 | 50 | MG | QID | ||||||||
| 125004982 | 12500498 | 20 | C | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 21 | C | MORPHINE | MORPHINE | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 22 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | UNTIL 3 MG/H | 0 | |||||||||||
| 125004982 | 12500498 | 23 | C | ZOPICLONE | ZOPICLONE | 1 | 1 INTAKE IN THE EVENING | 0 | QD | ||||||||||
| 125004982 | 12500498 | 24 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 25 | C | FONDAPARINUX SODIUM. | FONDAPARINUX SODIUM | 1 | UNK | 0 | |||||||||||
| 125004982 | 12500498 | 26 | C | VANCOMYCIN | VANCOMYCIN | 1 | Oral | 500 MG, 3X/DAY | 0 | 500 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125004982 | 12500498 | 3 | Rheumatoid arthritis |
| 125004982 | 12500498 | 4 | Postoperative analgesia |
| 125004982 | 12500498 | 7 | Rheumatoid arthritis |
| 125004982 | 12500498 | 8 | Rheumatoid arthritis |
| 125004982 | 12500498 | 9 | Thrombosis prophylaxis |
| 125004982 | 12500498 | 13 | Anaesthesia |
| 125004982 | 12500498 | 14 | Anaesthesia |
| 125004982 | 12500498 | 15 | Anaesthesia |
| 125004982 | 12500498 | 16 | Anaesthesia |
| 125004982 | 12500498 | 17 | Infection prophylaxis |
| 125004982 | 12500498 | 20 | Postoperative analgesia |
| 125004982 | 12500498 | 21 | Postoperative analgesia |
| 125004982 | 12500498 | 25 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125004982 | 12500498 | LT |
| 125004982 | 12500498 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125004982 | 12500498 | Agranulocytosis | |
| 125004982 | 12500498 | Blood folate decreased | |
| 125004982 | 12500498 | Bone marrow failure | |
| 125004982 | 12500498 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125004982 | 12500498 | 1 | 20160604 | 20160605 | 0 | |
| 125004982 | 12500498 | 2 | 20160610 | 0 | ||
| 125004982 | 12500498 | 3 | 20160603 | 20160603 | 0 | |
| 125004982 | 12500498 | 4 | 20160602 | 20160602 | 0 | |
| 125004982 | 12500498 | 5 | 20160609 | 0 | ||
| 125004982 | 12500498 | 6 | 20160606 | 20160609 | 0 | |
| 125004982 | 12500498 | 10 | 20160604 | 0 | ||
| 125004982 | 12500498 | 11 | 20160609 | 0 | ||
| 125004982 | 12500498 | 22 | 20160604 | 20160606 | 0 | |
| 125004982 | 12500498 | 23 | 20160607 | 20160609 | 0 | |
| 125004982 | 12500498 | 24 | 20160608 | 0 | ||
| 125004982 | 12500498 | 25 | 20160609 | 0 | ||
| 125004982 | 12500498 | 26 | 20160609 | 0 |